|
gptkbp:instanceOf
|
gptkb:chemical_compound
|
|
gptkbp:ATCCode
|
N04BA01
C01CA04
|
|
gptkbp:boilingPoint
|
not applicable (decomposes)
|
|
gptkbp:CASNumber
|
51-61-6
|
|
gptkbp:drugClass
|
vasopressor agent
inotropic agent
adrenergic agonist
|
|
gptkbp:foundIn
|
gptkb:adrenal_medulla
brain
human body
|
|
gptkbp:hasChEMBL
|
CHEMBL59
|
|
gptkbp:hasInChIKey
|
VYFYYTLLBUKUHU-UHFFFAOYSA-N
|
|
gptkbp:hasMolecularFormula
|
C8H11NO3
|
|
gptkbp:hasSMILES
|
C1=CC(=C(C=C1CCN)O)O
|
|
gptkbp:hasUNII
|
VDR09VTQ8Z
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
DB02546
|
|
gptkbp:isApprovedDrug
|
true
|
|
gptkbp:isEndogenous
|
true
|
|
gptkbp:isHormone
|
true
|
|
gptkbp:isNeurotransmitter
|
true
|
|
gptkbp:isSolubleIn
|
gptkb:beer
gptkb:water
gptkb:chloroform
Ether
|
|
gptkbp:IUPACName
|
4-(2-aminoethyl)benzene-1,2-diol
|
|
gptkbp:mechanismOfAction
|
adrenergic receptor agonist
dopamine receptor agonist
|
|
gptkbp:meltingPoint
|
128-130°C
|
|
gptkbp:metabolism
|
gptkb:COMT
MAO
|
|
gptkbp:molecularWeight
|
169.18 g/mol
|
|
gptkbp:predecessor
|
norepinephrine
epinephrine
|
|
gptkbp:pregnancyCategory
|
C (US)
|
|
gptkbp:PubChem_CID
|
gptkb:DB02546
681
CHEBI:18243
D07828
|
|
gptkbp:routeOfAdministration
|
intravenous
|
|
gptkbp:sideEffect
|
gptkb:arrhythmia
nausea
headache
tachycardia
|
|
gptkbp:synonym
|
gptkb:Dopamine
|
|
gptkbp:usedFor
|
gptkb:Parkinson's_disease
treatment of heart failure
treatment of shock
|
|
gptkbp:bfsParent
|
gptkb:vorinostat
|
|
gptkbp:bfsLayer
|
6
|